研究报告 |
|
|
|
|
miR-122过表达转基因小鼠质粒构建及其功能验证 |
马纪1,3,4, 孙奋勇2, 张越1,3,4, 洪岸1,3,4 |
1. 暨南大学生物工程研究所 广州 510632;
2. 上海市第十人民医院 上海 200072;
3. 广东省生物工程药物重点实验室 广州 510632;
4. 基因工程药物国家工程研究中心 广州 510632 |
|
The Construction Strategy of miR-122 Overexpression Plasmid in Transgenic Mouse Studies and Its Functional Verification |
MA Ji1,3,4, SUN Fen-yong2, ZHANG Yue1,3,4, HONG An1,3,4 |
1. Bioengineering Institute of Jinan University,Guangzhou 510632,China;
2. Shanghai Tenth People’s Hospital,Shanghai 200072,China;
3. Guang Dong Provincial Key Laboratory of Bioengineering Medicine,Guangzhou 510632,China;
4. National Engineering Research Center of Genetic Medicine,Guangzhou 510632,China |
引用本文:
马纪, 孙奋勇, 张越, 洪岸. miR-122过表达转基因小鼠质粒构建及其功能验证[J]. 中国生物工程杂志, 2011, 31(9): 28-34.
MA Ji, SUN Fen-yong, ZHANG Yue, HONG An. The Construction Strategy of miR-122 Overexpression Plasmid in Transgenic Mouse Studies and Its Functional Verification. China Biotechnology, 2011, 31(9): 28-34.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I9/28
|
[1] Calin G A, Croce C M. MicroRNA Signatures in Human Cancers. Nat Rev Cancer,2006,6(11):857-866.
[2] Garzon R, Fabbri M, Croce C M, et al. MicroRNA Expression and Function in Cancer. Trends Mol Med,2006,12(12):580-587.
[3] Zeng Y. Principles of micro-RNA Production and Maturation. Oncogene, 2006,25(46):6156-6162.
[4] Valencia-Sanchez M A, Liu J, Parker R, et al. Control of Translation and mRNA Degradation by miRNAs and siRNAs. Genes Dev, 2006,20(5):515-524.
[5] Corney D C, Flesken Nikitin A, Godwin A K, et al.MicroRNA-34b and MicroRNA-34c are Targets of p53 and Cooperate in Control of Cell Proliferation and Adhesion-independent Growth. Cancer Res, 2007, 67(18): 8433-8438.
[6] Chan J A, Krichevsky A M, Kosik K S.MicroRNA-21 is an Antiapoptotic Factor in Human Glioblastoma Cells. Cancer Res,2005,65(14):6029-6033.
[7] Stern Ginossar N, Elefant N, Zimmermann A, et al. Host Immune System Gene Targeting by a Viral miRNA.Science,2007,317(5836):376-381.
[8] Chang J,Nicolas E, Marks D,et al.Mir-122,a Mammlian Liver-specific microRNA,is Processed from Her mRNA and May Down regulate the High Affinity Cationic Amino Acid Transporter CAT-1.RNA Biology,2004,1(2):106-113.
[9] Girard M, Henrion Caude A. miR-122, a Paradigm for the Role of microRNAs in the Liver. Journal of Hepatology,2008,48(4):648-656.
[10] Coulouarn C, Thorgeirsson S S. Loss of miR-122 Expression in Liver Cancer Correlates with Suppression of the Hepatic Phenotype and Gain of Metastatic Properties. Oncogene, 2009, 28(40):3526-3536.
[11] Tsai W, Hsu P W, Tsou A, et al. microRNA-122, a Tumor Suppressor MicroRNA that Regulates Intrahepatic Metastasis of Hepatocellular Carcinoma. Hepatology,2009,49(5):1571-1582.
[12] Fornari F,Gramantieri L,Bolondi L,et al. MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. Cancer Res, 2009,69(14):5761-5767.
[13] Burchard J, Zhang C, Luk J M, et al.microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol,2010,24(6):402.
[14] Liu N, Andrew H, Olson E, et al. An Intragenic MEF2-dependent Enhancer Directs Muscle-specific Expression of microRNAs 1 and 133. Proc Natl Acad Sci USA, 2007,104(52):20844-20849.
[15] Hatley M E, Patrick D M, Olson E N,et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell, 2010,18(3):282-293.
[16] Genarino V A,SardielloMarco M,Avellino R,et al. MicroRNA Target Prediction by Wxpression Analysis of Host Genes. Genome Res,2009,19(3):481-490.
[17] Brian D B, Mary A V, Luigi N, et al. Endogenous microRNA Regulation Suppresses Transgene Expression in Hematopoietic Lineages and Enables Stable Gene Transfer. Nat Med, 2006,12(5):585-591.
[18] Zong Y, Wang H, Qin C, et al. miR-29c regulates BACE1 protein expression. Brain Res, 2011,13(1395):108-115.
[19] Ebert M S, Neilson J R, Sharp P A, MicroRNA Sensor reporter: Competitive Inhibitors of Small RNAs in Mammalian Cells. Nat Methods,2007, 4(9):721-726.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|